Detalhe da pesquisa
1.
Antibody Batch Cloning.
Methods Mol Biol
; 2702: 411-417, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679632
2.
Biomarker Discovery by ORFeome Phage Display.
Methods Mol Biol
; 2702: 543-561, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679638
3.
Antibody Selection via Phage Display in Microtiter Plates.
Methods Mol Biol
; 2702: 247-260, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679623
4.
Mapping Epitopes by Phage Display.
Methods Mol Biol
; 2702: 563-585, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679639
5.
Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2.
Emerg Microbes Infect
; 11(1): 1037-1048, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320064
6.
ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-CoV-2 Spike Protein.
Viruses
; 14(6)2022 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35746797
7.
Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment.
Viruses
; 14(10)2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36298643
8.
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.
Front Cell Infect Microbiol
; 11: 697876, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34307196
9.
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface.
Nat Commun
; 12(1): 1577, 2021 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33707427
10.
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations.
Cell Rep
; 36(4): 109433, 2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273271